Cleared Special

K180740 - VitriGuard

K180740 is the FDA 510(k) clearance for VitriGuard by Origio A/S. It is a Class 2 Obstetrics & Gynecology device (product code MQK) cleared through the Special 510(k) pathway after a 43-day FDA review.

K180740 · Origio A/S · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2018
Decision
43d
Days
Class 2
Risk

K180740 is an FDA 510(k) clearance for the VitriGuard. Classified as Labware, Assisted Reproduction (product code MQK), Class II - Special Controls.

Submitted by Origio A/S (Måløv, DK). The FDA issued a Cleared decision on May 4, 2018 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6160 - the FDA obstetrics and gynecology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Origio A/S devices

Submission Details

510(k) Number K180740 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 2018
Decision Date May 04, 2018
Days to Decision 43 days
Submission Type Special
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
117d faster than avg
Panel avg: 160d · This submission: 43d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MQK Labware, Assisted Reproduction
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

CooperSurgical, Inc.
Roaida Johnson

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQK Labware, Assisted Reproduction

All 18
Devices cleared under the same product code (MQK) and FDA review panel - the closest regulatory comparables to K180740.
VitriGuard
K200815 · Origio A/S · Jun 2020
Rapid-i™ Kit
K181461 · Vitrolife Sweden AB · Jan 2019
Cryotop®US-flash and Cryotop®US-scoop
K181469 · Kitazato Corporation · Nov 2018
ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device (850µl, 3ml)
K173075 · Dxnow, Inc. · Mar 2018
iVitri Straw
K172751 · Reprobitech Corp. · Feb 2018
RAPID-I KIT
K140207 · Vitrolife Sweden AB · Dec 2014